-
公开(公告)号:US20210189367A1
公开(公告)日:2021-06-24
申请号:US16771510
申请日:2018-12-11
IPC分类号: C12N9/50 , C07K14/705 , C12N5/0783 , A61K35/17 , C07K16/32 , C07K16/28
摘要: The present disclosure provides inducible cell receptors and therapeutic cells comprising the inducible cell receptors. Further provided are methods of preparing the therapeutic cells and methods of treating a subject by administering the therapeutic cells and regulating activity of (e.g. activating and/or inactivating) the cell receptors.
-
公开(公告)号:US20230235051A1
公开(公告)日:2023-07-27
申请号:US17820525
申请日:2022-08-17
发明人: Wilson Wong , Seunghee Lee , Russell Morrison Gordley , Marcela Guzman Ayala , Gary Lee , Nicholas Frankel , Xi Kang
IPC分类号: C07K16/28 , C07K14/725 , C07K14/705 , A61K39/00 , C07K16/32
CPC分类号: C07K16/2803 , C07K14/7051 , C07K14/70517 , C07K14/70521 , A61K39/4611 , A61K39/4621 , A61K39/4631 , A61K39/4643 , A61K39/4613 , C07K16/32 , A61K39/464406 , C07K2319/02 , C07K2319/03 , C07K2317/622 , C07K2319/43 , A61K2239/13 , A61K2239/21 , A61K2239/22
摘要: Provided herein are inhibitory chimeric antigen receptor compositions and cells comprising such compositions. Also provided are methods of using inhibitory chimeric antigen receptors and cells.
-
公开(公告)号:US20230272037A1
公开(公告)日:2023-08-31
申请号:US17820804
申请日:2022-08-18
IPC分类号: C07K14/725 , C07K14/705 , C07K14/47 , C12N15/63
CPC分类号: C07K14/7051 , C07K14/70596 , C07K14/4703 , C07K14/70521 , C12N15/63 , C07K2319/03 , C07K2319/02 , C07K2317/622 , C07K2317/55
摘要: Provided herein are inhibitory chimeric antigen receptor compositions and cells comprising such compositions. Also provided are methods of using inhibitory chimeric antigen receptors and cells.
-
公开(公告)号:US20230270789A1
公开(公告)日:2023-08-31
申请号:US17872827
申请日:2022-07-25
发明人: Timothy Kuan-Ta Lu , Russell Morrison Gordley , Jack Tzu-Chiao Lin , Brian Scott Garrison , Philip Janmin Lee , Alba Gonzalez-Junca , Don-Hong Wang
IPC分类号: A61K35/28 , A61P35/00 , A61K39/395
CPC分类号: A61K35/28 , A61P35/00 , A61K39/3955 , A61K2039/5156
摘要: Provided herein are methods and compositions for dynamically controlling and targeting multiple immunosuppressive mechanisms in cancer. Some aspects provide cells engineered to produce multiple effector molecules, each of which modulates a different immunosuppressive mechanisms of a tumor, as well as methods of using the cells to treat cancer, such as ovarian, breast, or colon cancer.
-
公开(公告)号:US20210228640A1
公开(公告)日:2021-07-29
申请号:US17219569
申请日:2021-03-31
发明人: Timothy Kuan-Ta Lu , Russell Morrison Gordley , Jack Tzu-Chiao Lin , Brian Scott Garrison , Philip Janmin Lee , Alba Gonzalez-Junca , Don-Hong Wang , Daniel Frimannsson
IPC分类号: A61K35/28 , A61P35/00 , C07K14/715 , C12N5/0775 , C12N15/63
摘要: Provided herein are methods and compositions for dynamically controlling and targeting multiple immunosuppressive mechanisms in cancer. Some aspects provide cells engineered to produce multiple effector molecules, each of which modulates a different immunosuppressive mechanisms of a tumor, as well as methods of using the cells to treat cancer, such as ovarian, breast, or colon cancer.
-
公开(公告)号:US10993967B2
公开(公告)日:2021-05-04
申请号:US16656452
申请日:2019-10-17
发明人: Timothy Kuan-Ta Lu , Russell Morrison Gordley , Jack Tzu-Chiao Lin , Brian Scott Garrison , Philip Janmin Lee , Alba Gonzalez-Junca , Don-Hong Wang , Daniel Frimannsson
IPC分类号: A61K35/28 , A61P35/00 , C07K14/715 , C12N5/0775 , C12N15/63 , C07K16/28 , C07K16/30
摘要: Provided herein are methods and compositions for dynamically controlling and targeting multiple immunosuppressive mechanisms in cancer. Some aspects provide cells engineered to produce multiple effector molecules, each of which modulates a different immunosuppressive mechanisms of a tumor, as well as methods of using the cells to treat cancer, such as ovarian, breast, or colon cancer.
-
公开(公告)号:US20240277765A1
公开(公告)日:2024-08-22
申请号:US18501925
申请日:2023-11-03
发明人: Brian Scott Garrison , Jennifer Chien , Kathryn Armstrong Loving , Russell Morrison Gordley , Michelle Elizabeth Hung
IPC分类号: A61K35/17 , A61K38/00 , C07K14/725 , C07K16/28
CPC分类号: A61K35/17 , C07K14/7051 , C07K16/2803 , C07K16/2863 , A61K38/00 , C07K2317/565 , C07K2317/622 , C07K2319/03
摘要: Provided herein are acute myeloid leukemia antigen targets for chimeric receptors and methods of using same.
-
公开(公告)号:US20240226296A9
公开(公告)日:2024-07-11
申请号:US18377191
申请日:2023-10-05
发明人: Michelle Elizabeth Hung , Rebecca Tayler Cottman , Russell Morrison Gordley , Gary Lee , Timothy Kuan-Ta Lu , Srinivasaraghavan Kannan , Chandra Shekhar Verma
IPC分类号: A61K39/00
CPC分类号: A61K39/4635 , A61K39/4613 , A61K39/463
摘要: Provided herein are mutants of estrogen receptor alpha ligand binding domain (ER-LBD), and chimeric proteins including such mutant ER-LBD. Also provided are methods of modulating transcription and modulating localization of such chimeric proteins.
-
公开(公告)号:US20200171093A1
公开(公告)日:2020-06-04
申请号:US16656452
申请日:2019-10-17
发明人: Timothy Kuan-Ta Lu , Russell Morrison Gordley , Jack Tzu-Chiao Lin , Brian Scott Garrison , Philip Janmin Lee , Alba Gonzalez-Junca , Don-Hong Wang , Daniel Frimannsson
IPC分类号: A61K35/28 , C12N5/0775 , C12N15/63 , C07K14/715 , A61P35/00
摘要: Provided herein are methods and compositions for dynamically controlling and targeting multiple immunosuppressive mechanisms in cancer. Some aspects provide cells engineered to produce multiple effector molecules, each of which modulates a different immunosuppressive mechanisms of a tumor, as well as methods of using the cells to treat cancer, such as ovarian, breast, or colon cancer.
-
公开(公告)号:US20240150433A1
公开(公告)日:2024-05-09
申请号:US18481805
申请日:2023-10-05
发明人: Michelle Elizabeth Hung , Rebecca Tayler Cottman , Russell Morrison Gordley , Gary Lee , Timothy Kuan-Ta Lu , Srinivasaraghavan Kannan , Chandra Shekhar Verma
IPC分类号: C07K14/72 , C07K14/715 , C12N15/85
CPC分类号: C07K14/721 , C07K14/7155 , C12N15/85 , C07K2319/09 , C12N2800/107 , C12N2830/002
摘要: Provided herein are mutants of estrogen receptor alpha ligand binding domain (ER-LBD), and chimeric proteins including such mutant ER-LBD. Also provided are methods of modulating transcription and modulating localization of such chimeric proteins.
-
-
-
-
-
-
-
-
-